CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Short Interest Update

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) saw a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 15,600 shares, a growth of 8.3% from the October 31st total of 14,400 shares. Based on an average daily volume of 92,100 shares, the short-interest ratio is presently 0.2 days.

CERo Therapeutics Trading Down 17.7 %

CERo Therapeutics stock traded down $0.00 during mid-day trading on Wednesday, hitting $0.01. The company’s stock had a trading volume of 21,299 shares, compared to its average volume of 68,257. The stock’s fifty day moving average is $0.01 and its two-hundred day moving average is $0.02. CERo Therapeutics has a 1 year low of $0.00 and a 1 year high of $0.25.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.